Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-08-10

Clinical Trial Update: Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is assessing the efficacy of etoricoxib in female patients with fibromyalgia. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arcoxia (Etoricoxib)

Snippet

Sponsor: Meir Medical Center | Conditions: Fibromyalgia | Phase 4 | Status: UNKNOWN